NZ700546A - Use of neuregulin to treat peripheral nerve injury - Google Patents
Use of neuregulin to treat peripheral nerve injuryInfo
- Publication number
- NZ700546A NZ700546A NZ700546A NZ70054613A NZ700546A NZ 700546 A NZ700546 A NZ 700546A NZ 700546 A NZ700546 A NZ 700546A NZ 70054613 A NZ70054613 A NZ 70054613A NZ 700546 A NZ700546 A NZ 700546A
- Authority
- NZ
- New Zealand
- Prior art keywords
- peripheral nerve
- neuregulin
- nerve injury
- treat peripheral
- injury
- Prior art date
Links
- 208000010886 Peripheral nerve injury Diseases 0.000 title abstract 3
- 102000014413 Neuregulin Human genes 0.000 title 1
- 108050003475 Neuregulin Proteins 0.000 title 1
- 102000048238 Neuregulin-1 Human genes 0.000 abstract 2
- 108090000556 Neuregulin-1 Proteins 0.000 abstract 2
- 208000014674 injury Diseases 0.000 abstract 2
- 208000004296 neuralgia Diseases 0.000 abstract 2
- 208000021722 neuropathic pain Diseases 0.000 abstract 2
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000005036 nerve Anatomy 0.000 abstract 1
- 230000001172 regenerating effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1883—Neuregulins, e.g.. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261618381P | 2012-03-30 | 2012-03-30 | |
| US201261674060P | 2012-07-20 | 2012-07-20 | |
| US201261693585P | 2012-08-27 | 2012-08-27 | |
| US201261693589P | 2012-08-27 | 2012-08-27 | |
| US201361785419P | 2013-03-14 | 2013-03-14 | |
| PCT/US2013/034634 WO2013149163A1 (en) | 2012-03-30 | 2013-03-29 | Use of neuregulin to treat peripheral nerve injury |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ700546A true NZ700546A (en) | 2017-05-26 |
Family
ID=48128617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ700546A NZ700546A (en) | 2012-03-30 | 2013-03-29 | Use of neuregulin to treat peripheral nerve injury |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20150094263A1 (enExample) |
| EP (3) | EP2830645B1 (enExample) |
| JP (4) | JP6420233B2 (enExample) |
| CN (2) | CN104321072A (enExample) |
| AU (4) | AU2013237896B2 (enExample) |
| BR (1) | BR112014024308B1 (enExample) |
| CA (1) | CA2869070A1 (enExample) |
| DK (2) | DK3278811T3 (enExample) |
| ES (2) | ES2647917T3 (enExample) |
| IL (3) | IL288785B2 (enExample) |
| MX (1) | MX354598B (enExample) |
| NZ (1) | NZ700546A (enExample) |
| PL (2) | PL3278811T3 (enExample) |
| PT (2) | PT2830645T (enExample) |
| WO (1) | WO2013149163A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3338791T3 (da) | 2008-07-17 | 2019-12-16 | Acorda Therapeutics Inc | Terapeutisk dosering af en neuregulin i behandling eller profylaxis af hjertesvigt |
| PL3235504T3 (pl) | 2009-10-14 | 2020-03-31 | Acorda Therapeutics, Inc. | Zastosowanie neureguliny do leczenia uszkodzenia nerwu obwodowego |
| ITUB20155471A1 (it) * | 2015-11-11 | 2017-05-11 | Univ Degli Studi Di Torino | Coniugato della neuregulina 1 per il trattamento delle lesioni dei nervi periferici |
| IL294038A (en) * | 2015-12-04 | 2022-08-01 | Univ Iowa Res Found | Device, systems and methods for prediction, screening and monitoring of encephalopathy / delirium |
| CA3082878C (en) | 2017-11-17 | 2024-02-20 | The Research Foundation for State University of New York | A method for treating damaged peripheral nerves using x-ray microbeam irradiation |
| CN110946991A (zh) * | 2018-09-27 | 2020-04-03 | 广州中医药大学(广州中医药研究院) | 神经调节蛋白1的应用 |
| CN114929099B (zh) * | 2019-08-01 | 2025-08-15 | 马克·埃文斯 | 用于在分娩期间和分娩之前降低人类胎儿神经损伤风险及鉴定神经损伤存在的方法和设备 |
| CN116116737B (zh) * | 2023-04-14 | 2023-06-30 | 新华手术器械有限公司 | 止血钳毛坯自动上料装置及使用方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US888A (en) | 1838-08-20 | perkins | ||
| US7037A (en) | 1850-01-22 | Grid-ikon slide-valve | ||
| US5716930A (en) | 1991-04-10 | 1998-02-10 | Ludwig Institute For Cancer Research | Glial growth factors |
| US5530109A (en) | 1991-04-10 | 1996-06-25 | Ludwig Institute For Cancer Research | DNA encoding glial mitogenic factors |
| US6087323A (en) * | 1992-04-03 | 2000-07-11 | Cambridge Neuroscience, Inc. | Use of neuregulins as modulators of cellular communication |
| US7037888B1 (en) | 1992-04-03 | 2006-05-02 | Acorda Therapeutics, Inc. | Methods for treating muscle diseases and disorders |
| EP1028735A4 (en) * | 1997-10-14 | 2003-08-06 | Cenes Pharmaceuticals Inc | THERAPEUTIC METHOD COMPRISING THE USE OF NEUREGULIN |
| CA2409996C (en) * | 2000-05-23 | 2016-03-01 | Cenes Pharmaceuticals, Inc. | Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| WO2009046453A2 (en) * | 2007-10-05 | 2009-04-09 | New England Medical Center (Nemc) | Use of neuregulin-1 in reducing brain damage |
| CN104645315A (zh) * | 2008-02-29 | 2015-05-27 | 阿索尔达治疗公司 | 达到所需胶质生长因子2血浆水平的方法 |
| DK3338791T3 (da) * | 2008-07-17 | 2019-12-16 | Acorda Therapeutics Inc | Terapeutisk dosering af en neuregulin i behandling eller profylaxis af hjertesvigt |
| KR101237927B1 (ko) * | 2009-05-07 | 2013-03-04 | (주)문엔제이 | 신경손상 및 신경질환 예방 또는 치료용 약학조성물 |
| PL3235504T3 (pl) * | 2009-10-14 | 2020-03-31 | Acorda Therapeutics, Inc. | Zastosowanie neureguliny do leczenia uszkodzenia nerwu obwodowego |
| CA2845198A1 (en) * | 2010-08-13 | 2012-02-16 | Georgetown University | Ggf2 and methods of use |
-
2013
- 2013-03-29 DK DK17187879.6T patent/DK3278811T3/da active
- 2013-03-29 AU AU2013237896A patent/AU2013237896B2/en not_active Ceased
- 2013-03-29 EP EP13716919.9A patent/EP2830645B1/en active Active
- 2013-03-29 JP JP2015503646A patent/JP6420233B2/ja not_active Expired - Fee Related
- 2013-03-29 IL IL288785A patent/IL288785B2/en unknown
- 2013-03-29 PL PL17187879T patent/PL3278811T3/pl unknown
- 2013-03-29 US US14/389,655 patent/US20150094263A1/en not_active Abandoned
- 2013-03-29 ES ES13716919.9T patent/ES2647917T3/es active Active
- 2013-03-29 CN CN201380026579.2A patent/CN104321072A/zh active Pending
- 2013-03-29 CN CN201610027758.3A patent/CN106511971A/zh active Pending
- 2013-03-29 PT PT137169199T patent/PT2830645T/pt unknown
- 2013-03-29 PT PT171878796T patent/PT3278811T/pt unknown
- 2013-03-29 CA CA2869070A patent/CA2869070A1/en active Pending
- 2013-03-29 PL PL13716919T patent/PL2830645T3/pl unknown
- 2013-03-29 WO PCT/US2013/034634 patent/WO2013149163A1/en not_active Ceased
- 2013-03-29 EP EP17187879.6A patent/EP3278811B1/en active Active
- 2013-03-29 ES ES17187879T patent/ES2857810T3/es active Active
- 2013-03-29 NZ NZ700546A patent/NZ700546A/en not_active IP Right Cessation
- 2013-03-29 BR BR112014024308-5A patent/BR112014024308B1/pt not_active IP Right Cessation
- 2013-03-29 DK DK13716919.9T patent/DK2830645T3/da active
- 2013-03-29 EP EP20211026.8A patent/EP3842059A1/en not_active Withdrawn
- 2013-03-29 MX MX2014011838A patent/MX354598B/es active IP Right Grant
-
2014
- 2014-09-29 IL IL234882A patent/IL234882B/en active IP Right Grant
-
2015
- 2015-12-22 US US14/978,287 patent/US20160346353A1/en not_active Abandoned
-
2017
- 2017-04-07 JP JP2017076415A patent/JP2017149746A/ja active Pending
-
2018
- 2018-01-24 AU AU2018200592A patent/AU2018200592A1/en not_active Abandoned
-
2019
- 2019-04-03 JP JP2019070976A patent/JP2019131582A/ja active Pending
- 2019-04-05 AU AU2019202401A patent/AU2019202401B2/en not_active Ceased
-
2020
- 2020-03-09 IL IL273186A patent/IL273186B/en unknown
- 2020-10-30 AU AU2020260539A patent/AU2020260539A1/en not_active Abandoned
-
2021
- 2021-01-15 JP JP2021004728A patent/JP7108724B2/ja active Active
-
2022
- 2022-03-28 US US17/705,840 patent/US20230117985A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ700546A (en) | Use of neuregulin to treat peripheral nerve injury | |
| PH12014501776A1 (en) | Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof | |
| NZ709392A (en) | Synergistic bacterial compositions and methods of production and use thereof | |
| MX2014008705A (es) | Compuestos tricíclicos de sulfona y métodos para elaborarlos y utilizarlos. | |
| IN2015DN04085A (enExample) | ||
| MX343135B (es) | Compuestos de tipo fumagilol y métodos de realización y uso de los mismos. | |
| HK1210599A1 (en) | Abuse deterrent pharmaceutical compositions for controlled release | |
| EA201590654A1 (ru) | Комбинация разагилина и придопидина для лечения нейродегенеративных нарушений, в частности болезни хантингтона | |
| MX356755B (es) | Compuestos de tipo fumagilol y metodos para su elaboración y uso. | |
| MX343687B (es) | Compuestos sulfonamida tricíclica y métodos para su fabricación y uso. | |
| IN2015DN03219A (enExample) | ||
| MX2013006595A (es) | Tratamiento de lesion de la medula espinal y lesion traumatica del cerebro empleando celulas madre placentarias. | |
| MY167232A (en) | Polypeptides binding to human complement c5 | |
| MX2014008706A (es) | Compuestos tricíclicos de sulfonamida y métodos para elaborarlos y usarlos. | |
| EP4509181A3 (en) | Utilisation d'akkermansia pour le traitement de troubles métaboliques | |
| WO2012047630A3 (en) | N-alkyl or n-aryl substituted guanide and biguanide compounds and methods of their use | |
| NZ728284A (en) | Treatment and prevention of the common cold using povidone-iodine | |
| MX2013007995A (es) | Peptidos derivados de lactoferrina humana y su uso. | |
| HK1218251A1 (zh) | 用拉喹莫德治疗多发性硬化症 | |
| IN2014DN10075A (enExample) | ||
| TW201613583A (en) | Laquinimod for the treatment of relapsing- remitting multiple sclerosis (RRMS) patients with a high disability status | |
| MX2015005732A (es) | Compuestos tricíclicos y métodos para hacer y utilizar los mismos. | |
| MX2015000485A (es) | Tratamiento de esclerosis multiple con una combinacion de laquinimod y fampridina. | |
| WO2011153377A3 (en) | Methods and compositions for treating a subject for central nervous system (cns) injury | |
| MX364528B (es) | Witanólidos útiles para el tratamiento de enfermedades neurodegenerativas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 29 MAR 2019 BY COMPUTER PACKAGES INC Effective date: 20180302 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 29 MAR 2020 BY COMPUTER PACKAGES INC Effective date: 20190302 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 29 MAR 2021 BY COMPUTER PACKAGES INC Effective date: 20200303 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 29 MAR 2022 BY COMPUTER PACKAGES INC Effective date: 20210309 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 29 MAR 2023 BY CPA GLOBAL Effective date: 20220224 |
|
| LAPS | Patent lapsed |